Goldman Sachs’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Buy |
596,698
+120,821
| +25% | +$140K | ﹤0.01% | 4074 |
|
|
2025
Q1 | $642K | Buy |
475,877
+29,177
| +7% | +$39.4K | ﹤0.01% | 4112 |
|
|
2024
Q4 | $5.88M | Buy |
446,700
+99,303
| +29% | +$1.31M | ﹤0.01% | 2733 |
|
|
2024
Q3 | $3.89M | Buy |
347,397
+134,159
| +63% | +$1.5M | ﹤0.01% | 2928 |
|
|
2024
Q2 | $2.29M | Sell |
213,238
-289,333
| -58% | -$3.11M | ﹤0.01% | 3117 |
|
|
2024
Q1 | $7.49M | Buy |
502,571
+115,325
| +30% | +$1.72M | ﹤0.01% | 2281 |
|
|
2023
Q4 | $7.01M | Buy |
387,246
+222,132
| +135% | +$4.02M | ﹤0.01% | 2346 |
|
|
2023
Q3 | $2.86M | Sell |
165,114
-60,909
| -27% | -$1.06M | ﹤0.01% | 2858 |
|
|
2023
Q2 | $4.1M | Sell |
226,023
-37,490
| -14% | -$679K | ﹤0.01% | 2701 |
|
|
2023
Q1 | $7.01M | Buy |
263,513
+116,156
| +79% | +$3.09M | ﹤0.01% | 2271 |
|
|
2022
Q4 | $2.85M | Buy |
147,357
+44,791
| +44% | +$866K | ﹤0.01% | 3032 |
|
|
2022
Q3 | $2.14M | Sell |
102,566
-328,658
| -76% | -$6.87M | ﹤0.01% | 3317 |
|
|
2022
Q2 | $3.45M | Buy |
431,224
+288,539
| +202% | +$2.31M | ﹤0.01% | 2993 |
|
|
2022
Q1 | $1M | Buy |
142,685
+45,057
| +46% | +$316K | ﹤0.01% | 4098 |
|
|
2021
Q4 | $1.32M | Buy |
97,628
+64,562
| +195% | +$872K | ﹤0.01% | 3816 |
|
|
2021
Q3 | $558K | Buy |
33,066
+7,660
| +30% | +$129K | ﹤0.01% | 4327 |
|
|
2021
Q2 | $739K | Buy |
25,406
+10,689
| +73% | +$311K | ﹤0.01% | 4210 |
|
|
2021
Q1 | $579K | Sell |
14,717
-3,348
| -19% | -$132K | ﹤0.01% | 4265 |
|
|
2020
Q4 | $410K | Buy |
+18,065
| New | +$410K | ﹤0.01% | 3933 |
|
|
2020
Q3 | – | Sell |
-45,000
| Closed | -$1.46M | – | 4539 |
|
|
2020
Q2 | $1.46M | Buy |
+45,000
| New | +$1.46M | ﹤0.01% | 3017 |
|